#1,602
in 💰 Finance

JNap’s Biotech Thoughts

About the Substack

Thoughts on biotech and pharmaceutical stocks from Bio5C founder, JNap.

Free Subscription Benefits

  • Occasional public posts

Paid Subcription Benefits

  • Subscriber-only posts and full archive
  • Subscriber-only episodes in your podcast app
  • Post comments and join the community

Paid Subscription Plans

  • $25 a month
  • $250 a year

About JNap

Head of Research for Remsen Investors LP, a long/short biopharma fund and owner of Bio5C, an independent biopharma research service. Decent at golf.

Is this your Substack? Submit changes.

JNap’s Biotech Thoughts's recommended Substacks

Bio Breakdowns logo
Adu Subramanian

Bio Breakdowns

Healthcare lies at the confluence of science, clinical practice, and regulation. I analyze trends, data, and diseases with eye toward biotech and a touch of humor

Matt Gamber’s Biotech Newsletter logo
Matt Gamber

Matt Gamber’s Biotech Newsletter

Weekly posts on small and mid-cap biotech stocks. 100% independent and reader supported with no company sponsored content or hedge fund compensation of any kind. See free performance posts for more information. Not financial advice, for research purposes.

100+
paid subscribers
Pufferfish Capital logo
Pufferfish Capital

Pufferfish Capital

Equity Research

A Failure to Communicate... the Truth logo
A Failure to Communicate

A Failure to Communicate... the Truth

Biotech, Markets and Macro

The Hermit logo
Alejandro Yela

The Hermit

+20.43% CAGR since 2018. Real-money small-cap research balancing long-term compounders with catalyst-driven multibaggers. Full track record and historical case studies on the About page.

100+
paid subscribers